Cryoport Inc (CYRX)
Official siteINDUSTRIALS • INTEGRATED FREIGHT & LOGISTICS • NASDAQ
Market Cap: $1.00B
Last updated: Nov 17, 2026 at 4:29 PM ET
Cryoport Inc (CYRX) Statistics
Cryoport (CYRX) has a market cap of $1.00B and an enterprise value of $910.76M. It kept -20.88% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 9.18% below the market cap, as cash exceeds debt.
| Market Cap | $1.00B |
|---|---|
| Enterprise Value | $910.76M |
| Latest price (Nov 17, 2026) | $19.74 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 5.2x and 2.1x. Its year-end P/S ranged from 2.0x to 22.2x from 2016 to 2025.
| P/S Ratio | 5.2x |
|---|---|
| Forward P/S | 5.1x |
| P/B Ratio | 2.1x |
| P/TBV Ratio | 3.0x |
| P/OCF Ratio | 91.2x |
Price Statistics
The stock is up 127.68% over 52 weeks and trades 12.16% above its 50-day average.
| Beta (1Y) | 1.59 |
|---|---|
| 52-Week Change | +127.68% |
| 1-Month Change | +16.25% |
| 3-Month Change | +21.03% |
| 6-Month Change | +51.50% |
| 5-Year Change | -78.80% |
| 10-Year Change | +743.41% |
| Total Return (1Y) | +127.68% |
| Total Return (3Y CAGR) | +13.16% |
| Total Return (5Y CAGR) | -23.03% |
| Return vs SPY (1Y) | +123.72% |
| Max Drawdown (1Y) | -31.50% |
| Max Drawdown (3Y) | -75.04% |
| Sharpe Ratio (1Y) | 1.75 |
| Correlation with SPY (1Y) | 0.44 |
| 50-Day Average | $17.60 |
| 200-Day Average | $13.81 |
| 52-Week Range | $7.61 to $21.78 |
| RSI (14 Days) | 59.8 |
| Average Volume (20 Days) | 1.26M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.04x current liabilities, and total debt is 0.39x shareholder equity.
| Current Ratio | 2.04x |
|---|---|
| Quick Ratio | 1.94x |
| Debt / Equity | 0.39x |
| Interest Coverage | -15.72x |
Returns and Efficiency
Return on invested capital is -4.92% over the last 12 months, against a 5-year average of -15.05%.
| Return on Equity (ROE) | -8.31% |
|---|---|
| Return on Assets (ROA) | -5.35% |
| Return on Invested Capital (ROIC) | -4.92% |
| Return on Capital Employed (ROCE) | -6.27% |
| ROE (5Y Average) | -21.87% |
| ROA (5Y Average) | -11.82% |
| ROIC (5Y Average) | -15.05% |
| Asset Turnover | 0.25x |
| Inventory Turnover | 4.65x |
| Receivables Turnover | 5.31x |
| Cash Conversion Cycle | 89 days |
Scores
CYRX has an Altman Z-Score of 1.39, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.39 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $192.44M over the last 12 months is up 1.15% from the 12 months before.
| Revenue | $192.44M |
|---|---|
| Revenue Growth (YoY) | +1.15% |
| Gross Profit | $90.28M |
| Operating Income | -$38.49M |
| Pretax Income | -$35.13M |
| Net Income | -$40.18M |
| EBITDA | -$7.21M |
| EBIT | -$33.03M |
| Reported EPS (TTM) | -$0.81 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 64.39% of the $750.95M in total assets.
| Cash and Equivalents | $279.18M |
|---|---|
| Total Debt | $187.09M |
| Net Cash | $92.09M |
| Net Cash Per Share | $1.82 |
| Working Capital | $232.53M |
| Shareholder Equity | $483.51M |
| Book Value Per Share | $9.55 |
| Tangible Book Value | $328.21M |
| Tangible Book Per Share | $6.48 |
| Total Assets | $750.95M |
| Total Liabilities | $267.43M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $29.28M of capital spending, operating cash flow left -$18.28M of free cash flow.
| Operating Cash Flow | $11.00M |
|---|---|
| Capital Expenditures | $29.28M |
| Free Cash Flow | -$18.28M |
| FCF Per Share | -$0.36 |
| Depreciation and Amortization | $25.81M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -20.00%, against a 5-year average of -19.95%.
| Gross Margin | 46.91% |
|---|---|
| Operating Margin | -20.00% |
| Pretax Margin | -18.25% |
| Net Margin | -20.88% |
| EBITDA Margin | -3.75% |
| EBIT Margin | -17.16% |
| FCF Margin | -9.50% |
| Gross Margin (5Y Average) | 44.05% |
| Operating Margin (5Y Average) | -19.95% |
| Net Margin (5Y Average) | -52.31% |
Growth
Revenue fell 7.50% a year over 3 years.
| Revenue Growth (3Y CAGR) | -7.50% |
|---|---|
| Revenue Growth (5Y CAGR) | +17.49% |
| Book Value Per Share Growth (2Y CAGR) | +0.57% |
| Tangible Book Per Share Growth (2Y CAGR) | +34.46% |
Dividends and Yields
CYRX does not pay a dividend. Its free cash flow yield is -1.83%.
| FCF Yield | -1.83% |
|---|---|
| Shareholder Yield | 2.00% |
Stock Splits
The last split was a 1-for-12 reverse split on May 19, 2015.
| Last Split Date | May 19, 2015 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Peer Position
Against 11 similar companies, CYRX has the 2nd highest P/S.
P/S RatioPeer median 1.0x
ROICPeer median 4.50%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.54%
| P/S Ratio | 5.2x vs 1.0x median |
|---|---|
| ROIC | -4.92% vs 4.50% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +1.15% vs +10.54% median |
Analyst Forecast
Consensus estimates put revenue growth at 11.28% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +11.28% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CYRX
What is CYRX's market cap?
Cryoport has a market cap of $1.00B. Its enterprise value, which adds debt and subtracts cash, is $910.76M.
How many shares of CYRX are outstanding?
Cryoport has 50.65M shares outstanding. The count is up 1.05% from a year earlier.
Does CYRX pay a dividend?
No. Cryoport does not pay a dividend.
How much debt does CYRX have?
Cryoport has $187.09M of total debt and $279.18M of cash and equivalents, a net cash position of $92.09M.
CYRX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors